NOTCH3 and JAGGED2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 an MUC5AC expression

Histopathology

Volumn 61, Issue 4, 2012, Pages 576-586

  Kang, Haeyoun ^a   An, Jung Hee ^a   Song, Ji Ye ^a   Kim, Tae Heon ^a   Heo, Jin Hyung ^a   Ahn, Dae Ho ^a   Kim, Gwangil ^a  

^a CHA University   (South Korea)

Author keywords

Gastric cancer; MUC2; MUC5AC; Notch; Quantitative real time polymerase chain reaction (qRT PCR)

Indexed keywords

JAGGED1; JAGGED2 PROTEIN; MEMBRANE PROTEIN; MUCIN 2; MUCIN 5AC; NOTCH1 RECEPTOR; NOTCH3 RECEPTOR; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; JAG2 PROTEIN, HUMAN; MUC2 PROTEIN, HUMAN; MUC5AC PROTEIN, HUMAN; NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; ADENOCARCINOMA; BIOSYNTHESIS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; VERY ELDERLY; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUCIN 5AC; MUCIN-2; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; STOMACH NEOPLASMS; TRANSCRIPTOME;

EID: 84871926998     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04274.x     Document Type: Article

References (32)

1. Kim TH, Shivdasani RA. Notch signaling in stomach epithelial stem cell homeostasis. J. Exp. Med. 2011; 208; 677-688.
2. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004; 6; R605-R615.
3. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis- Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005; 435; 964-968.
4. Gallahan D, Jhappan C, Robinson G et al. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res. 1996; 56; 1775-1785.
5. Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 2003; 22; 6598-6608.
6. Miyamoto Y, Maitra A, Ghosh B et al. Notch mediates TGF alphainduced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003; 3; 565-576.
7. Sander GR, Powell BC. Expression of notch receptors and ligands in the adult gut. J. Histochem. Cytochem. 2004; 52; 509-516.
8. Leow CC, Romero MS, Ross S, Polakis P, Gao WQ. Hath1, downregulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res. 2004; 64; 6050-6057.
9. Koch U, Radtke F. Notch and cancer: a double-edged sword. Cell. Mol. Life Sci. 2007; 64; 2746-2762.
10. Chen X, Leung SY, Yuen ST et al. Variation in gene expression patterns in human gastric cancers. Mol. Biol. Cell 2003; 14; 3208-3215.
11. Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch. 2002; 440; 304-310.
12. Kang JH, Lee EH, Park SW, Chung IY. MUC5AC expression through bidirectional communication of Notch and epidermal growth factor receptor pathways. J. Immunol. 2011; 187; 222-229.
13. Garg P, Ravi A, Patel NR et al. Matrix metalloproteinase-9 regulates MUC-2 expression through its effect on goblet cell differentiation. Gastroenterology 2007; 132; 1877-1889.
14. Sekine A, Akiyama Y, Yanagihara K, Yuasa Y. Hath1 upregulates gastric mucin gene expression in gastric cells. Biochem. Biophys. Res. Commun. 2006; 344; 1166-1171.
15. Doucas H, Mann CD, Sutton CD et al. Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J. Surg. Oncol. 2008; 97; 63-68.
16. Mazur PK, Riener MO, Jochum W et al. Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer. Am. J. Gastroenterol. 2012; 107; 126-135.
17. Zhang Y, Li B, Ji ZZ, Zheng PS. Notch1 regulates the growth of human colon cancers. Cancer 2010; 116; 5207-5218.
18. Mumm JS, Kopan R. Notch signaling: from the outside in. Dev. Biol. 2000; 228; 151-165.
19. Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006; 107; 2223-2233.
20. Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat. Rev. Cancer 2003; 3; 756-767.
21. Katoh M. Notch signaling in gastrointestinal tract [Review]. Int. J. Oncol. 2007; 30; 247-251.
22. Croquelois A, Blindenbacher A, Terracciano L et al. Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice. Hepatology 2005; 41; 487-496.
23. Shou J, Ross S, Koeppen H, de Sauvage FJ, Gao WQ. Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res. 2001; 61; 7291-7297.
24. Sriuranpong V, Borges MW, Ravi RK et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001; 61; 3200-3205.
25. Katoh M. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int. J. Mol. Med. 2006; 17; 681-685.
26. Yeh TS, Wu CW, Hsu KW et al. The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res. 2009; 69; 5039-5048.
27. Sun Y, Gao X, Liu J et al. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers. Arch. Pathol. Lab. Med. 2011; 135; 451-458.
28. Nyeng P, Norgaard GA, Kobberup S, Jensen J. FGF10 signaling controls stomach morphogenesis. Dev. Biol. 2007; 303; 295-310.
29. van Es JH, van Gijn ME, Riccio O et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435; 959-963.
30. Droy-Dupre L, Vallee M, Bossard C, Laboisse CL, Jarry A. A multiparametric approach to monitor the effects of {gamma}- secretase inhibition along the whole intestinal tract. Dis. Model Mech. 2012; 5; 107-114.
31. Ilhan O, Han U, Onal B, Celik SY. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma. Turk. J. Gastroenterol. 2010; 21; 345-352.
32. Zecchini V, Domaschenz R, Winton D, Jones P. Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells. Genes Dev. 2005; 19; 1686-1691.